How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Terminal Care Market
- By Care Setting: Hospice Care, Home-Based Care, Hospital-Based Care, Nursing Homes, Palliative Care Centers
- By Service Provider: Hospice Agencies, Home Health Agencies, Skilled Nursing Facilities, Hospitals, Specialized Palliative Care Teams
- By Patient Age Group: Pediatric Terminal Care, Adult Terminal Care, Geriatric Terminal Care
- By Disease Type: Cancer, Cardiovascular Diseases, Neurodegenerative Diseases, Respiratory Diseases, End-Stage Renal Disease
- By Service Type: Pain Management, Psychosocial Support, Spiritual Care, Symptom Management, Bereavement Support
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Hospice Care leads By Care Setting at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 300 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.183 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.191 →
Full report · locked preview
Everything inside the Terminal Care Market report
A complete, evidence-based study - 12 chapters and 126 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Care Setting 5
Service Provider 5
Patient Age Group 3
Disease Type 5
Service Type 5
Companies profiled
Kindred Healthcare
Genesis Healthcare
Brookdale Senior Living
Amedisys Inc.
LHC Group
Encompass Health Corporation
HCR ManorCare
Consulate Health Care
Sage Hospice
VITAS Healthcare
Chemed Corporation (VITAS)
Addus HomeCare Corporation
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Kindred Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Genesis Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Brookdale Senior Living
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Amedisys Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →LHC Group
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Encompass Health Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →HCR ManorCare
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Consulate Health Care
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Sage Hospice
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →VITAS Healthcare
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Chemed Corporation (VITAS)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Addus HomeCare Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Almost Family Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Gentiva Health Services
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Curo Health Services
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$1,410M by 2033 · 11.3% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Hospice Care37.0
- Home-Based Care17.8
- Hospital-Based Care16.9
- Nursing Homes14.5
- Palliative Care Centers13.7
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$198.2M → $482.4M · 11.8%
Europe$138.1M → $318.0M · 11.0%
Asia Pacific$126.1M → $276.6M · 10.3%
Latin America$78.1M → $199.7M · 12.5%
Middle East and Africa$60.1M → $128.1M · 9.9%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →11.202026
11.232027
11.232028
11.262029
11.262030
11.272031
11.282032
11.302033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Kindred Healthcare14.2
- Genesis Healthcare12.7
- Brookdale Senior Living10.7
- Amedisys Inc.12.4
- LHC Group5.3
- Encompass Health Corporation16.7
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Care Setting22.5%
Service Provider18.4%
Patient Age Group17.3%
Disease Type17.0%
Service Type24.8%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.3
- Europe22.6
- Asia Pacific19.7
- Latin America14.2
- Middle East and Africa9.1
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Kindred Healthcare | 83 | 82 | 77 | 85 | 89 | 92 | 85 |
| Genesis Healthcare | 74 | 90 | 72 | 93 | 69 | 73 | 79 |
| Brookdale Senior Living | 72 | 76 | 75 | 74 | 78 | 64 | 73 |
| Amedisys Inc. | 65 | 72 | 69 | 68 | 67 | 71 | 69 |
| LHC Group | 53 | 71 | 61 | 57 | 52 | 60 | 59 |
| Encompass Health Corporation | 68 | 67 | 54 | 69 | 52 | 51 | 60 |
| HCR ManorCare | 65 | 55 | 56 | 42 | 60 | 63 | 57 |
| Consulate Health Care | 37 | 41 | 44 | 56 | 39 | 52 | 45 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Kindred Healthcare
- Genesis Healthcare
- Brookdale Senior Living
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Kindred Healthcare | ✓ | ◐ | ◐ | ◐ | ✓ | ✓ |
| Genesis Healthcare | ✓ | ◐ | ◐ | ✓ | − | ✓ |
| Brookdale Senior Living | ◐ | ✓ | ✓ | ◐ | ✓ | ◐ |
| Amedisys Inc. | ◐ | ◐ | − | ◐ | ◐ | ◐ |
| LHC Group | − | ✓ | − | − | − | ◐ |
| Encompass Health Corporation | ◐ | ◐ | − | ◐ | − | − |
| HCR ManorCare | ◐ | ◐ | − | − | ◐ | ◐ |
| Consulate Health Care | − | − | − | ◐ | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Kindred Healthcare85
2Genesis Healthcare79
3Brookdale Senior Living73
4Amedisys Inc.69
5Encompass Health Corporation60
6LHC Group59
7HCR ManorCare57
8Consulate Health Care45
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Kindred HealthcareGenesis Healthcare
Challenger2
Strong scale, closing on the leaders.
Brookdale Senior LivingAmedisys Inc.
Contender3
Focused players with pockets of strength.
LHC GroupEncompass Health CorporationHCR ManorCare
Niche1
Specialists in a single segment or region.
Consulate Health Care
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Care Setting in North America, then scale across Terminal Care Market — a $112M beachhead inside a $1.78B market.
Beachhead (SOM)$112Mobtainable near-term
Serviceable (SAM)$613Mreachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion86 fit
Hospice Care
Best fit — highest urgency & budget in Care Setting.
Economic buyer81 fit
Home-Based Care
Strong fit — clear ROI and a fast path to value.
End user64 fit
Hospital-Based Care
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Care Setting in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Service Provider & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Patient Age Group
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel28%
Digital / self-serve21%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Care Setting leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Terminal Care Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified40%
Sales qualified23%
Evaluation12%
Closed-won5%
$15.1KCAC
$61KLTV
4.1:1LTV : CAC
< 2 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Terminal Care Market is a resilient opportunity — $1.47B by 2033, compounding at 5.2%.
TAM · 2025$982Mtoday
TAM · 2033$1.47Bforecast
CAGR5.2%2027–2033
Cumulative$10.9Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$1.47BTotal addressable market
SAM$603MServiceable available market
SOM$111MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →5.2% CAGR
Demand compounds through 2033, outpacing GDP across Care Setting.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Care Setting moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$1.47BLarge & growingTAM by 2033 at 5.2% CAGR
$603MServiceable nowreachable with today’s model
$111MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$1.15BBear3.4% CAGR
$1.47BBase5.2% CAGR
$1.88BBull6.8% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Service Provider optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Terminal Care Market — a $1.77B market by 2033. Plan: grow share from 10.0% to 17.6%.
Market size · 2033$1.77Btotal addressable
Market CAGR3.4%2027–2033
Target share17.6%from 10.0% today
Revenue ambition$311Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 10.0% | 17.6% | Behind |
| Revenue | $164M | $311M | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Behind |
| Gross margin | 31.5% | 43.8% | Ahead |
| Customer retention | 88.2% | 92.0% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Care Setting
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Service Provider capability
A defensible second engine — invest in Service Provider to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Care Setting share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Service Provider
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $36M capacity & capability investment
- Greenlight bolt-on M&A in Service Provider
- Authorise North America expansion plan
- Fund R&D program for Care Setting leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskBehind
- Regulatory / policy changeAhead
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Terminal Care Market conversation — a $11.1B market you can size, segment and defend in minutes.
Market size · 2033$11.1Btotal opportunity
Growth9.0%CAGR to 2033
Addressable buyers1,301+accounts in scope
Typical ROI4.7×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Care Setting
Goal Grow share in Care Setting
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.7×return on cost, year one
< 4 mopayback period
$45K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Kindred HealthcareGenesis HealthcareBrookdale Senior LivingAmedisys Inc.LHC GroupEncompass Health CorporationHCR ManorCareConsulate Health Care+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Terminal Care Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Terminal Care Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Terlipressin Injection Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportTerizidone Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportTeriparatide Injection Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportTeriparatide API Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportTeriparatide Acetate Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportTeriflunomide Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportTerfenadine Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportTerconazole Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportTerbutaline Sulphate API Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportTerbutaline Sulfate Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportTerbutaline Sulfate Injection Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportTerbutaline Sulfate API Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.